Stock analysts at Zacks Research decreased their FY2024 EPS estimates for AbbVie in a research report issued to clients and investors on Wednesday, January 15th. Zacks Research analyst S. Ganoria now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback